See All Slides - tctmd.com

Slides

Presentation TCT 2012

DES Restenosis: Treatment Options and Recurrent Event Rates

Presenter: Alaide Chieffo

October 22, 2012

Presentation TCT 2012

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

RESOLVE: A Multicenter Study Evaluating the Diagnostic Accuracy of iFR Compared to FFR

Presenter: Allen Jeremias

October 22, 2012

Presentation TCT 2012

When Do I Prefer Transcarotid Alternative Access for TAVR?

Presenter: Vasilis Babaliaros

October 22, 2012

Presentation TCT 2012

REDUCE Trial Update

Presenter: John Rhodes

October 22, 2012

Presentation TCT 2012

Case 1: Complex CAD: CABG or PCI?

Presenter: Murat Cayli

October 22, 2012

Presentation TCT 2012

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

The Apica Left Ventricular Apical Access and Closure System: First-in-Human Use Experiences During TAVR

Presenter: Thomas Walther

October 22, 2012

Presentation TCT 2012

Intentional Risk “Drift” vs. Refinement in Risk Assessment: Data from SOURCE and Personal Experiences

Presenter: Martyn Thomas

October 22, 2012

Presentation TCT 2012

Case 3(2)

Presenter: Horst Sievert

October 22, 2012

Advertisement

Slides

DES Restenosis: Treatment Options and Recurrent Event Rates

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

RESOLVE: A Multicenter Study Evaluating the Diagnostic Accuracy of iFR Compared to FFR

When Do I Prefer Transcarotid Alternative Access for TAVR?

REDUCE Trial Update

Case 1: Complex CAD: CABG or PCI?

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

The Apica Left Ventricular Apical Access and Closure System: First-in-Human Use Experiences During TAVR

Intentional Risk “Drift” vs. Refinement in Risk Assessment: Data from SOURCE and Personal Experiences

Case 3(2)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content